Sabin Vaccine Institute President Dr. Peter Hotez is leading the research at Texas Children’s Hospital and Baylor College of Medicine to develop the first-ever vaccine for Chagas disease.

"It was safer. It was more effective, conferring immunity that might last a lifetime.

Recently there has been a great deal of good news for children suffering from vaccine-preventable diseases.

Sabin Executive Vice-President, Ciro de Quadros, M.D., M.P.H., recently co-authored two new papers that will appear this month in the Strüngmann Forum Report entitled, "Disease Eradication in the 21st Century: Implications for Global Health.” The 

Since the rotavirus vaccine was introduced in 2007, diarrhea-related deaths among Mexican children under the age of 5 have been cut nearly in half.

One thing I have noticed about Dr. Sabin by reading his correspondence is that he is passionate. Whether it is his stance on the effectiveness of the oral polio vaccine, biomedical research, or humanitarianism, Dr.

Sabin Executive Vice President Dr. Ciro de Quadros attended this week’s Pacific Health Summit in Seattle, Washington. The theme of the 2011 conference was vaccines.

A key message in our Sustainable Immunization Financing (SIF) Program work is that countries need to reduce their dependencies by appropriating their routine immunization programs.

In partnership with the Fraunhofer Center for Molecular Biotechnology and the Walter Reid Army Institute for Research, the Sabin Vaccine Institute has successfully expressed the hookworm-derived antigen Na-APR-1.

Pages

Subscribe to RSS - Sabin Vaccine Development